In osteosarcoma, Spautin-1–mediated inhibition of USP13 degrades METTL3, destabilizing ATG5 mRNA and impairing autophagy and glycolysis, which ultimately suppresses tumor growth (275). Here, METTL3 is linked to osteosarcoma.